However, higher levels of HNF1B indicated better overall survival in bladder carcinoma (HR=0.5, p=4.5e-06), kidney renal papillary cell carcinoma (HR=0.35, p=0.00032), (HR=0.37, p=0.04), and uterine corpus endometrial carcinoma (HR=0.58, p=0.0095) (Figure 4). Here, HNF1B is linked to uterine corpus endometrial carcinoma.